(Q43407813)

23 November 2017

title

Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice (English)

1 reference

23 November 2017

Feng-Cheng Chou

1

1 reference

23 November 2017

Shing-Jia Shieh

series ordinal

2

1 reference

23 November 2017

Huey-Kang Sytwu

series ordinal

3

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 September 2009

1 reference

European Journal of Immunology

23 November 2017

published in

1 reference

23 November 2017

volume

39

1 reference

23 November 2017

issue

9

1 reference

23 November 2017

page(s)

2403-2411

1 reference

The expanding universe of T-cell subsets: Th1, Th2 and more.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

TIM family of genes in immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

The NOD mouse: a model of immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Autoimmune diabetes: how many steps for one disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Role of T-cell anergy and suppression in susceptibility to IDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Dysregulated T cell expression of TIM3 in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Lack of TIM-3 immunoregulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Th2-driven, allergen-induced airway inflammation is reduced after treatment with anti-Tim-3 antibody in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

T Cell Ig- and mucin-domain-containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

7 January 2021

T helper cell subsets in insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

7 January 2021

Immunopathogenic role of TH1 cells in autoimmune diabetes: evidence from a T1 and T2 doubly transgenic non-obese diabetic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

7 January 2021

Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

7 January 2021

Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

7 January 2021

Cutting edge: T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200839177

7 January 2021

Identifiers

DOI

10.1002/EJI.200839177

1 reference

23 November 2017

1 reference